文献速递病毒性肝炎

STING通路激活经肝巨噬细胞抑制HBV复制

Stimulation of the STING pathway leads to inhibition of HBV replication: insights into the role of hepatic macrophages.
PubMed 文献 · J Infect Dis · 2026-08-12

该研究检测慢性乙型肝炎患者PBMC和肝活检标本中STING表达,并在持续HBV复制小鼠模型中评估STING激动剂DMXAA的抗病毒效应及巨噬细胞的作用。结果显示免疫活跃期STING表达更高,DMXAA剂量依赖性降低血清HBV DNA并减少HBsAg、HBeAg,而清除肝巨噬细胞后抗病毒效果减弱。

要点

  • CHB患者免疫活跃期STING表达高于非活跃期和健康对照。
  • DMXAA剂量依赖性降低持续HBV复制小鼠血清HBV DNA。
  • 清除肝巨噬细胞后DMXAA的抗病毒效果减弱。

核心结论

  • STING通路激活通过上调免疫相关基因增强抗HBV免疫应答。
  • 肝巨噬细胞在STING介导的HBV复制抑制中起重要作用。

研究设计与样本

  • 检测CHB患者外周血单个核细胞和肝活检标本的STING表达。
  • 在rAAV8-HBV1.3持续HBV复制小鼠模型中评估DMXAA效应。
  • 体内清除巨噬细胞以评估其在DMXAA抗病毒效应中的作用。

主要发现

  • CHB患者免疫活跃期STING表达高于非活跃期或未感染健康对照。
  • DMXAA剂量依赖性降低小鼠血清HBV DNA。
  • 重复给药降低血清HBV DNA、HBsAg和HBeAg并增强肝脏免疫应答。
  • 肝组织转录组测序发现856个差异表达基因参与免疫相关信号通路。
  • 肝巨噬细胞清除后DMXAA引起的HBV病毒学标志物下降减弱。

临床怎么用

  • 提示STING通路是HBV免疫治疗的可探索靶点。
  • 肝巨噬细胞参与STING介导的抗HBV效应,支持其作为免疫调节环节。

局限性

  • 主要证据来自小鼠模型,人体临床验证尚缺乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Activation of the host immune system is a promising strategy for treating hepatitis B (HBV). The stimulator of interferon genes (STING) signaling pathway acts as an innate immune sensor for viral DNA. We aimed to determine whether STING activation can inhibit HBV replication in the liver. METHODS: We evaluated STING expression in peripheral blood mononuclear cells (PBMCs) and liver biopsy specimens from patients with chronic hepatitis B (CHB). We examined the effect of the STING agonist DMXAA on HBV replication and the immune response in a mouse model with persistent HBV replication (rAAV8-HBV1.3). Additionally, we depleted macrophages in vivo to assess their role in DMXAA's antiviral effects. RESULTS: STING expression in CHB patients was higher in the immune-active phase than in the inactive phase or uninfected healthy controls, suggesting an association between elevated STING expression and immune activation. In a mouse model with persistent HBV replication, DMXAA reduced serum HBV DNA in a dose-dependent manner, whereas repeated administration reduced serum HBV DNA, HBsAg, and HBeAg levels and enhanced hepatic immune responses. Transcriptome sequencing of liver tissues revealed 856 differentially expressed genes (DEGs) involved in immune-related signaling pathways. In hepatic macrophage-depleted mice, the reductions in HBV virological markers following DMXAA treatment were less pronounced. CONCLUSIONS: STING pathway activation enhances the immune response against HBV by upregulating the expression of immune-related genes. Hepatic macrophages play an important role in STING-mediated inhibition of HBV replication.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Zhang M, Wang X, Xu H, et al. Stimulation of the STING pathway leads to inhibition of HBV replication: insights into the role of hepatic macrophages. J Infect Dis. 2026. PMID: 42583801. doi:10.1093/infdis/jiag413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。